MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with L

Lormetazepam

Lormetazepam 1mg tablets

Use with caution

Stability notes for Lormetazepam 1mg tablets

Protect from from moisture.

Provenance

This compatibility recommendation is derived from Lormetazepam 500 microgram and 1mg tablets (Thornton & Ross Ltd).

Suppliers (7) of Lormetazepam 1mg tablets
Lormetazepam 1mg tablets (A A H Pharmaceuticals Ltd)
Lormetazepam 1mg tablets (Alliance Healthcare (Distribution) Ltd)
Lormetazepam 1mg tablets (Genus Pharmaceuticals Holdings Ltd)
Lormetazepam 1mg tablets (Medihealth (Northern) Ltd)
Lormetazepam 1mg tablets (Necessity Supplies Ltd)
Lormetazepam 1mg tablets (Phoenix Healthcare Distribution Ltd)
Lormetazepam 1mg tablets (Sigma Pharmaceuticals Plc)

Lormetazepam 500microgram tablets

Use with caution

Stability notes for Lormetazepam 500microgram tablets

Protect from from moisture.

Provenance

This compatibility recommendation is derived from Lormetazepam 500 microgram and 1mg tablets (Thornton & Ross Ltd).

Suppliers (6) of Lormetazepam 500microgram tablets
Lormetazepam 500microgram tablets (A A H Pharmaceuticals Ltd)
Lormetazepam 500microgram tablets (Alliance Healthcare (Distribution) Ltd)
Lormetazepam 500microgram tablets (Genus Pharmaceuticals Holdings Ltd)
Lormetazepam 500microgram tablets (Medihealth (Northern) Ltd)
Lormetazepam 500microgram tablets (Phoenix Healthcare Distribution Ltd)
Lormetazepam 500microgram tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.